Thank you.
I just have one more question for Mr. Wright. In his submission on page 3, it says, “The volume of work CDR performs is determined by the number of drugs that are submitted to it by industry—” We have heard in other meetings—not so much on this topic—that the volume of new drugs coming through the pipeline has diminished considerably in the last few years. So if in fact the number of new drugs coming forward is diminishing, how could the volume of work be going up and therefore require this increase in the budget from $2 million to $3.4 million for the last two years?